Episode 208: drinks with diabetes, new Paxlovid trial, antiplatelet agents in stroke, and dietary advice from the AHA

<p>This week, primary care doctors Mark Ebell, Kate Rowland, Henry Barry and Gary Ferenchick discuss four new studies: whether water is better than diet drinks in diabetes, a new RCT of Paxlovid for COVID in contemporary patients, to switch or not to switch antiplatelet agents after a stroke, and the latest AHA 2026 dietary advice for heart health.</p><p>Drinks for diabetes: <a href="https://pubmed.ncbi.nlm.nih.gov/41369640/"><u>ttps://pubmed.ncbi.nlm.nih.gov/41369640/</u></a> </p><p>Antiplatelet agents after stroke on aspirin: <a href="https://pubmed.ncbi.nlm.nih.gov/41347302/"><u>https://pubmed.ncbi.nlm.nih.gov/41347302/</u></a> </p><p>New Paxlovid trial: <a href="https://pubmed.ncbi.nlm.nih.gov/42019019/"><u>https://pubmed.ncbi.nlm.nih.gov/42019019/</u></a> </p><p>AHA 2026 dietary guidance: <a href="https://pubmed.ncbi.nlm.nih.gov/41914202/"><u>https://pubmed.ncbi.nlm.nih.gov/41914202/</u></a> </p><p><br></p>